Subscribe

Pulmonx Corporation (LUNG)

USD1.50 +0.02 (+1.01%)
US NASDAQ Healthcare Medical - Devices
Address 700 Chesapeake Drive 94063
Redwood City, CA, US
CEO Glendon E. French
Website pulmonx.com
IPO 2020-10-01
CIK 1127537 ISIN US7458481014

Explore sections of this company profile

Description

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.50 +0.02 (+1.01%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
488.8K
Beta
0.28
Float Shares
37.27M
Free Float %
88.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.79% +6.45% +28.91% +4.43% +1.85% -25.34% -51.47% -85.66% -96.20% -95.80% -95.80%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (9 ratings, all time) Buy
Price Targets & DCF
Current price
1.50
Low 2.50 +67.2%
Consensus 10.00 +568.9%
Median 9.75 +552.2%
High 20.00 +1,237.8%
DCF (Levered) 7.47 +399.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 67% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 4 0
Hold 2 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month — —
Last Quarter — —
Last Year 2
3.25
+117.4%
All Time 10
10.90
+629.1%
Quality scores
Altman Z-Score
-5.62
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Devices: +11.2%
    +8.0% Q1'26: -8.7% (vs Q1'25)
  • ✗
    EPS growth Medical - Devices: +28.5%
    +7.6% Q1'26: +8.3% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Devices: +30.9%
    -64.9% Q1'26: -49.1% (vs Q1'25)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    -59.3% Q1'26: -62.9% (vs Q1'25)
  • ✗
    ROIC Medical - Devices: +3.3%
    -132.6% Q1'26: -128.0% (vs Q1'25)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +4.0% Q1'26: +4.9% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -1.07× Q1'26: -1.10× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.18) × ERP
WACC = 54% × Ke + 46% × Kd (5.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 1.50
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
4 Rev. Ana.
4 EPS Ana. 		Dec 2027
4 Rev. Ana.
4 EPS Ana. 		Dec 2028
4 Rev. Ana.
4 EPS Ana. 		Dec 2029
3 Rev. Ana.
2 EPS Ana. 		Dec 2030
3 Rev. Ana.
2 EPS Ana.
Revenue
32.73M
est: 31.74M (+3.1%)
48.42M
est: 49.00M (-1.2%)
53.66M
est: 52.16M (+2.9%)
68.68M
est: 76.58M (-10.3%)
83.79M
est: 82.32M (+1.8%)
90.50M
est: 89.63M (+1.0%)
90.87M
90.75M – 90.99M
+1.4% YoY
106.93M
104.17M – 109.68M
+17.7% YoY
132.53M
130.04M – 134.54M
+23.9% YoY
265.52M
260.53M – 269.56M
+100.4% YoY
357.11M
350.40M – 362.54M
+34.5% YoY
EBITDA
-28.44M
est: -26.92M (-5.6%)
-46.62M
est: -50.76M (+8.1%)
-55.99M
est: -54.24M (-3.2%)
-55.09M
est: -9.91M (-455.8%)
-50.79M
est: -10.66M (-376.7%)
-52.61M
est: -11.60M (-353.4%)
-11.76M
-11.78M – -11.75M
-1.4% YoY
-13.84M
-14.20M – -13.48M
-17.7% YoY
-17.15M
-17.42M – -16.83M
-23.9% YoY
-34.37M
-34.89M – -33.72M
-100.4% YoY
-46.22M
-46.93M – -45.36M
-34.5% YoY
EBIT
-28.84M
est: -27.41M (-5.2%)
-47.49M
est: -51.51M (+7.8%)
-57.50M
est: -55.22M (-4.1%)
-57.04M
est: -10.31M (-453.0%)
-52.39M
est: -11.09M (-372.5%)
-53.66M
est: -12.07M (-344.5%)
-12.24M
-12.26M – -12.22M
-1.4% YoY
-14.40M
-14.77M – -14.03M
-17.7% YoY
-17.85M
-18.12M – -17.51M
-23.9% YoY
-35.76M
-36.30M – -35.09M
-100.4% YoY
-48.09M
-48.83M – -47.19M
-34.5% YoY
Net Income
-32.23M
est: -86.73M (+62.8%)
-48.66M
est: -53.02M (+8.2%)
-58.92M
est: -56.89M (-3.6%)
-60.84M
est: -60.97M (+0.2%)
-56.39M
est: -63.20M (+10.8%)
-54.00M
est: -59.40M (+9.1%)
-46.34M
-47.16M – -45.52M
+22.0% YoY
-36.33M
-38.45M – -34.22M
+21.6% YoY
-20.69M
-26.49M – -14.89M
+43.1% YoY
61.64M
60.13M – 62.86M
+397.9% YoY
111.89M
109.16M – 114.10M
+81.5% YoY
SGA
46.07M
est: 44.41M (+3.7%)
69.87M
est: 68.57M (+1.9%)
83.11M
est: 72.97M (+13.9%)
94.61M
est: 102.74M (-7.9%)
102.14M
est: 110.44M (-7.5%)
101.31M
est: 120.25M (-15.7%)
121.91M
121.75M – 122.08M
+1.4% YoY
143.45M
139.75M – 147.15M
+17.7% YoY
177.79M
174.45M – 180.50M
+23.9% YoY
356.21M
349.52M – 361.63M
+100.4% YoY
479.09M
470.09M – 486.37M
+34.5% YoY
EPS
-0.90
est: -2.22 (+59.4%)
-1.35
est: -1.35 (-0.1%)
-1.59
est: -1.62 (+1.9%)
-1.60
est: -1.50 (-6.5%)
-1.44
est: -1.56 (+7.6%)
-1.33
est: -1.46 (+9.1%)
-1.14
-1.16 – -1.12
+22.2% YoY
-0.89
-0.95 – -0.84
+21.6% YoY
-0.49
-0.65 – -0.37
+45.3% YoY
1.52
1.48 – 1.54
+410.2% YoY
2.75
2.68 – 2.80
+81.5% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-04-30 D. Boral Capital Buy Buy Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-26 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-19 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-18 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-29.22M
OE per share TTM
-0.71
Owner's Yield
-42.27%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
22.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
115
Total invested
40.96M
Insider transactions (90d)
0
Beneficial owners (>5%)
32
Beneficial owners (>5%)
# Reporting person ⇅ Amount owned ⇅ % of class ⇅ Sole voting ⇅ Shared voting ⇅ Sole dispositive ⇅ Shared dispositive ⇅ Type Citizenship Filing date ⇅ SEC filing
1 Boston Scientific Corporation 5.99M 16.80% 5.99M — 5.99M — CO Delaware 2021-02-12 ↗
2 Abigail P. Johnson 3.31M 8.64% — — 3.31M — IN United States of America 2024-02-09 ↗
3 FMR LLC 3.31M 8.64% 3.30M — 3.31M — HC United States of America 2024-02-09 ↗
4 (1) BlackRock, Inc. 2.72M 7.40% 2.70M — 2.72M — HC Delaware 2022-02-04 ↗
5 The Vanguard Group - 23-1945930 2.52M 6.85% — 49.2K — 69.6K IA Pennsylvania For 2022-02-10 ↗
6 Company, L.P. 2.47M 6.59% — 2.47M — — PN Delaware 2023-02-13 ↗
7 Deerfield Mgmt, L.P. 2.47M 6.59% — 2.47M — — PN Delaware 2023-02-13 ↗
8 Deerfield Partners, L.P. 2.47M 6.59% — 2.47M — — PN Delaware 2023-02-13 ↗
9 James E. Flynn 2.47M 6.59% — 2.47M — — IN United States 2023-02-13 ↗
10 Morgan Stanley 1.95M 5.20% 13.00 1.95M — 1.95M HC, CO — 2023-02-10 ↗
11 Steven A. Cohen 1.94M 5.00% — 1.94M — — IN United States 2024-02-29 ↗
12 Point72 Asset Management, L.P. 1.91M 5.00% — 1.91M — — PN Delaware 2024-02-29 ↗
13 Point72 Capital Advisors, Inc. 1.91M 5.00% — 1.91M — — CO Delaware 2024-02-29 ↗
14 Efrem Kamen 1.88M 5.06% — 1.88M — 1.88M HC, IN USA 2022-05-25 ↗
15 Pura Vida Investments, LLC 1.88M 5.06% — 1.88M — 1.88M IA Delaware 2022-05-25 ↗
16 Fan Yu 1.41M 4.20% — 1.41M — — IN Hong Kong 2020-10-13 ↗
17 ABG Innovation Capital Partners III GP Limited 833.3K 2.50% — 833.3K — — CO Cayman Islands 2020-10-13 ↗
18 ABG Innovation Capital Partners III GP, L.P. 833.3K 2.50% — 833.3K — — PN Cayman Islands 2020-10-13 ↗
19 ABG-Pulmonx Limited 833.3K 2.50% — 833.3K — — CO British Virgin Islands 2020-10-13 ↗
20 Ally Bridge Group Innovation Capital Partners III, L.P. 833.3K 2.50% — 833.3K — — PN Cayman Islands 2020-10-13 ↗
21 ABG WTT- Pulmonx Limited 815.0K 2.40% — 815.0K — — CO Cayman Islands 2020-10-13 ↗
22 ABG-WTT Global Life Science Capital Partners GP Limited 815.0K 2.40% — 815.0K — — CO Cayman Islands 2020-10-13 ↗
23 ABG-WTT Global Life Science Capital Partners GP, L.P. 815.0K 2.40% — 815.0K — — PN Cayman Islands 2020-10-13 ↗
24 Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. 815.0K 2.40% — 815.0K — — PN Cayman Islands 2020-10-13 ↗
25 ABG Management Ltd. 578.0K 1.70% — 578.0K — — CO Cayman Islands 2020-10-13 ↗
26 ABG YY Limited 303.0K 0.90% — 303.0K — — CO British Virgin Islands 2020-10-13 ↗
27 Ally Bridge Group (NY) LLC 275.0K 0.80% — 275.0K — — OO State of Delaware 2020-10-13 ↗
28 Ally Bridge MedAlpha Management GP, LLC 275.0K 0.80% — 275.0K — — OO Cayman Islands 2020-10-13 ↗
29 Ally Bridge MedAlpha Management L.P. 275.0K 0.80% — 275.0K — — PN Cayman Islands 2020-10-13 ↗
30 Ally Bridge MedAlpha Master Fund L.P. 275.0K 0.80% — 275.0K — — PN Cayman Islands 2020-10-13 ↗
31 Cubist Systematic Strategies, LLC 22.5K 0.10% — 22.5K — — OO Delaware 2024-02-29 ↗
32 95-1411037 13.00 7.50% 2.75M — 2.75M — IA Delaware 2022-02-11 ↗

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
115
-1 vs prev Q
New positions
20
Closed positions
20
Increased
58
Reduced
37
Put/Call ratio
0.00
Calls held
—
Puts held
107.6K
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 NANO CAP NEW MILLENNIUM GROWTH FUND L P 85.0K +85.0K (+100.0%) 187.85M +187.9M (+100.0%) 0.21% +0.208 pp 0.16% +0.160 pp USD2.21 +0.0% 1 qtrs NEW
2 PRIMECAP MANAGEMENT CO/CA/ 4.73M -228.9K (-4.6%) 10.45M +2.4M (+30.1%) 11.55% -0.783 pp 0.01% +0.002 pp USD38.24 -94.2% 21 qtrs —
3 MORGAN STANLEY 4.16M +539.8K (+14.9%) 9.19M +3.3M (+56.8%) 10.16% +1.155 pp 0.00% +0.000 pp USD9.40 -76.5% 21 qtrs —
4 BLACKROCK, INC. 2.71M +31.4K (+1.2%) 5.98M +1.6M (+38.0%) 6.61% -0.044 pp 0.00% +0.000 pp USD8.19 -73.0% 6 qtrs —
5 VANGUARD GROUP INC 2.54M +298.3K (+13.3%) 5.61M +2.0M (+54.6%) 6.21% +0.628 pp 0.00% +0.000 pp USD34.49 -93.6% 21 qtrs —
6 SOLEUS CAPITAL MANAGEMENT, L.P. 2.04M +2.0M (+100.0%) 4.50M +4.5M (+100.0%) 4.98% +4.979 pp 0.17% +0.166 pp USD2.21 +0.0% 1 qtrs NEW
7 EXODUSPOINT CAPITAL MANAGEMENT, LP 1.95M +2.0M (+100.0%) 4.31M +4.3M (+100.0%) 4.77% +4.766 pp 0.03% +0.034 pp USD2.21 +0.0% 1 qtrs NEW
8 SILVERCREST ASSET MANAGEMENT GROUP LLC 1.26M +— (+0.0%) 2.79M +745.9K (+36.4%) 3.09% -0.057 pp 0.02% +0.006 pp USD5.38 -58.9% 4 qtrs —
9 DEUTSCHE BANK AG\ 1.13M +— (+0.0%) 2.49M +664.3K (+36.4%) 2.75% -0.051 pp 0.00% +0.000 pp USD9.14 -75.8% 21 qtrs —
10 GEODE CAPITAL MANAGEMENT, LLC 906.5K -72.2K (-7.4%) 2.00M +417.9K (+26.4%) 2.21% -0.221 pp 0.00% +0.000 pp USD31.87 -93.1% 21 qtrs —
11 STATE STREET CORP 821.2K +28.8K (+3.6%) 1.81M +531.2K (+41.4%) 2.01% +0.035 pp 0.00% +0.000 pp USD27.18 -91.9% 21 qtrs —
12 BRAIDWELL LP 752.5K +— (+0.0%) 1.66M +444.0K (+36.4%) 1.84% -0.034 pp 0.05% +0.017 pp USD8.43 -73.8% 13 qtrs —
13 BANK OF AMERICA CORP /DE/ 727.8K +248.8K (+51.9%) 1.61M +832.4K (+107.3%) 1.78% +0.586 pp 0.00% +0.000 pp USD3.14 -29.6% 21 qtrs —
14 PARKMAN HEALTHCARE PARTNERS LLC 727.8K +227.1K (+45.4%) 1.61M +797.3K (+98.3%) 1.78% +0.532 pp 0.15% +0.069 pp USD5.68 -61.1% 6 qtrs —
15 D. E. SHAW & CO., INC. 561.3K -228.0K (-28.9%) 1.24M -38.2K (-3.0%) 1.37% -0.593 pp 0.00% +0.000 pp USD6.54 -66.2% 13 qtrs —
16 STONEPINE CAPITAL MANAGEMENT, LLC 486.4K -183.6K (-27.4%) 1.07M -10.5K (-1.0%) 1.19% -0.479 pp 0.78% -0.098 pp USD1.83 +20.8% 3 qtrs —
17 BARCLAYS PLC 472.3K +378.1K (+401.8%) 1.04M +263.5K (+33.8%) 1.15% +0.920 pp 0.00% +0.000 pp USD2.84 -22.2% 16 qtrs —
18 JPMORGAN CHASE & CO 426.8K -70.3K (-14.1%) 943.2K +137.9K (+17.1%) 1.04% -0.194 pp 0.00% +0.000 pp USD7.26 -69.6% 21 qtrs —
19 GSA CAPITAL PARTNERS LLP 403.8K -351.7K (-46.6%) 892.0K -332.0K (-27.1%) 0.99% -0.893 pp 0.08% -0.025 pp USD2.16 +2.3% 6 qtrs —
20 GOLDMAN SACHS GROUP INC 365.2K -29.7K (-7.5%) 807.1K +167.4K (+26.2%) 0.89% -0.090 pp 0.00% +0.000 pp USD8.22 -73.1% 21 qtrs —
21 ADAR1 CAPITAL MANAGEMENT, LLC 355.4K +140.9K (+65.7%) 785.5K +438.0K (+126.0%) 0.87% +0.335 pp 0.06% +0.025 pp USD2.41 -8.3% 5 qtrs —
22 NORTHERN TRUST CORP 337.1K -25.2K (-7.0%) 745.1K +158.0K (+26.9%) 0.82% -0.078 pp 0.00% +0.000 pp USD36.75 -94.0% 21 qtrs —
23 RENAISSANCE TECHNOLOGIES LLC 292.0K -40.8K (-12.3%) 645.3K +106.2K (+19.7%) 0.71% -0.115 pp 0.00% +0.000 pp USD5.83 -62.1% 13 qtrs —
24 JEFFERIES FINANCIAL GROUP INC. 285.1K +— (+0.0%) 630.1K +168.2K (+36.4%) 0.70% -0.013 pp 0.00% +0.001 pp USD8.05 -72.5% 13 qtrs —
25 CFM WEALTH PARTNERS LLC 264.0K +— (+0.0%) 583.5K +155.8K (+36.4%) 0.65% -0.012 pp 0.08% +0.022 pp USD8.43 -73.8% 13 qtrs —
26 BIRCHVIEW CAPITAL, LP 250.6K +250.6K (+100.0%) 553.8K +553.8K (+100.0%) 0.61% +0.612 pp 0.32% +0.324 pp USD2.21 +0.0% 1 qtrs NEW
27 KOTLER KEVIN 200.0K +200.0K (+100.0%) 442.0K +442.0K (+100.0%) 0.49% +0.489 pp 0.10% +0.103 pp USD2.21 +0.0% 1 qtrs NEW
28 SUSQUEHANNA INTERNATIONAL GROUP, LLP 189.4K +121.6K (+179.4%) 418.7K +308.8K (+281.2%) 0.46% +0.294 pp 0.00% +0.000 pp USD3.71 -40.4% 16 qtrs —
29 WESTFIELD CAPITAL MANAGEMENT CO LP 184.9K +184.9K (+100.0%) 408.6K +408.6K (+100.0%) 0.45% +0.452 pp 0.00% +0.002 pp USD2.21 +0.0% 1 qtrs NEW
30 ACADIAN ASSET MANAGEMENT LLC 178.0K -33.2K (-15.7%) 391.0K +50.0K (+14.7%) 0.43% -0.091 pp 0.00% +0.000 pp USD1.74 +27.0% 3 qtrs —
31 JACOBS LEVY EQUITY MANAGEMENT, INC 174.8K -20.0K (-10.3%) 386.3K +70.7K (+22.4%) 0.43% -0.058 pp 0.00% +0.000 pp USD2.59 -14.7% 13 qtrs —
32 UBS GROUP AG 171.6K +90.3K (+111.1%) 379.2K +247.5K (+188.0%) 0.42% +0.217 pp 0.00% +0.000 pp USD3.11 -28.9% 21 qtrs —
33 DIMENSIONAL FUND ADVISORS LP 168.2K -176.3K (-51.2%) 372.0K -186.2K (-33.4%) 0.41% -0.446 pp 0.00% +0.000 pp USD11.32 -80.5% 15 qtrs —
34 JANE STREET GROUP, LLC 165.0K -83.2K (-33.5%) 364.6K -37.5K (-9.3%) 0.40% -0.215 pp 0.00% +0.000 pp USD3.41 -35.2% 20 qtrs —
35 TWO SIGMA INVESTMENTS, LP 132.8K +86.3K (+185.8%) 293.4K +218.2K (+289.9%) 0.32% +0.209 pp 0.00% +0.000 pp USD3.42 -35.4% 19 qtrs —
36 SCHONFELD STRATEGIC ADVISORS LLC 120.7K -103.4K (-46.1%) 266.7K -96.3K (-26.5%) 0.29% -0.263 pp 0.00% -0.001 pp USD7.00 -68.4% 6 qtrs —
37 XTX TOPCO LTD 111.2K -61.9K (-35.8%) 245.9K -34.7K (-12.4%) 0.27% -0.159 pp 0.01% -0.008 pp USD1.94 +13.9% 9 qtrs —
38 ALGERT GLOBAL LLC 99.7K +22.0K (+28.3%) 220.0K +94.0K (+74.6%) 0.24% +0.050 pp 0.00% +0.001 pp USD1.98 +11.6% 3 qtrs —
39 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 93.2K -14.8K (-13.7%) 205.9K +31.0K (+17.7%) 0.23% -0.041 pp 0.00% +0.000 pp USD35.72 -93.8% 21 qtrs —
40 BANK OF NEW YORK MELLON CORP 92.8K -3.4K (-3.5%) 205.1K +49.3K (+31.6%) 0.23% -0.013 pp 0.00% +0.000 pp USD29.52 -92.5% 21 qtrs —
41 FMR LLC 75.2K -2.1M (-96.5%) 166.2K -3.4M (-95.3%) 0.18% -5.226 pp 0.00% 0.000 pp USD10.72 -79.4% 21 qtrs —
42 NUVEEN, LLC 68.8K +— (+0.0%) 152.0K +40.6K (+36.4%) 0.17% -0.003 pp 0.00% +0.000 pp USD6.73 -67.2% 4 qtrs —
43 BRIDGEWAY CAPITAL MANAGEMENT, LLC 65.8K +— (+0.0%) 145.4K +38.8K (+36.4%) 0.16% -0.003 pp 0.00% +0.001 pp USD8.22 -73.1% 6 qtrs —
44 SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 60.3K +60.3K (+100.0%) 133.2K +133.2K (+100.0%) 0.15% +0.147 pp 0.00% +0.002 pp USD2.21 +0.0% 3 qtrs —
45 AQR CAPITAL MANAGEMENT LLC 58.9K +34.8K (+144.6%) 130.2K +91.2K (+233.6%) 0.14% +0.084 pp 0.00% +0.000 pp USD3.98 -44.5% 9 qtrs —
46 RHUMBLINE ADVISERS 56.2K -2.9K (-4.9%) 124.3K +28.5K (+29.7%) 0.14% -0.010 pp 0.00% +0.000 pp USD29.18 -92.4% 21 qtrs —
47 ALLIANCEBERNSTEIN L.P. 52.2K +— (+0.0%) 115.4K +30.8K (+36.4%) 0.13% -0.002 pp 0.00% +0.000 pp USD28.62 -92.3% 21 qtrs —
48 PERKINS CAPITAL MANAGEMENT INC 49.0K +28.0K (+133.3%) 108.3K +74.3K (+218.3%) 0.12% +0.067 pp 0.09% +0.056 pp USD2.16 +2.3% 3 qtrs —
49 ENGINEERS GATE MANAGER LP 48.2K +48.2K (+100.0%) 106.5K +106.5K (+100.0%) 0.12% +0.118 pp 0.00% +0.001 pp USD2.21 +0.0% 1 qtrs NEW
50 WELLS FARGO & COMPANY/MN 47.6K +23.8K (+100.4%) 105.2K +66.7K (+173.4%) 0.12% +0.057 pp 0.00% +0.000 pp USD5.34 -58.6% 21 qtrs —
51 BANCO BTG PACTUAL S.A. 46.3K +46.3K (+100.0%) 102.4K +102.4K (+100.0%) 0.11% +0.113 pp 0.02% +0.018 pp USD2.21 +0.0% 1 qtrs NEW
52 CITADEL ADVISORS LLC 45.3K -171.9K (-79.2%) 100.0K -251.8K (-71.6%) 0.11% -0.430 pp 0.00% +0.000 pp USD3.27 -32.4% 21 qtrs —
53 MERCER GLOBAL ADVISORS INC /ADV 41.3K -41.2K (-50.0%) 91.2K -42.4K (-31.7%) 0.10% -0.104 pp 0.00% 0.000 pp USD6.77 -67.4% 5 qtrs —
54 SQUAREPOINT OPS LLC 41.3K +41.3K (+100.0%) 91.2K +91.2K (+100.0%) 0.10% +0.101 pp 0.00% +0.000 pp USD2.21 +0.0% 8 qtrs —
55 FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND 40.0K -36.3K (-47.5%) 88.4K -35.6K (-28.7%) 0.10% -0.092 pp 0.00% 0.000 pp USD2.59 -14.7% 3 qtrs —
56 SIMPLEX TRADING, LLC 34.5K -4.6K (-11.8%) 76.3K +13.3K (+21.1%) 0.08% -0.013 pp 0.00% +0.000 pp USD1.77 +24.9% 4 qtrs —
57 FNY INVESTMENT ADVISERS, LLC 34.5K +16.1K (+87.8%) 76.0K +47.0K (+162.1%) 0.08% +0.039 pp 0.02% +0.012 pp USD1.90 +16.3% 2 qtrs —
58 WORTH VENTURE PARTNERS, LLC 32.5K +32.5K (+100.0%) 71.9K +71.9K (+100.0%) 0.08% +0.080 pp 0.52% +0.521 pp USD2.21 +0.0% 1 qtrs NEW
59 JAIN GLOBAL LLC 30.6K +11.8K (+62.9%) 67.6K +37.2K (+122.2%) 0.07% +0.028 pp 0.00% +0.000 pp USD1.85 +19.5% 2 qtrs —
60 MILLENNIUM MANAGEMENT LLC 29.5K -306.3K (-91.2%) 65.3K -478.8K (-88.0%) 0.07% -0.763 pp 0.00% 0.000 pp USD4.10 -46.1% 17 qtrs —
61 TUDOR INVESTMENT CORP ET AL 22.9K -188.2K (-89.1%) 50.6K -291.4K (-85.2%) 0.06% -0.469 pp 0.00% -0.001 pp USD8.06 -72.6% 12 qtrs —
62 VERITION FUND MANAGEMENT LLC 22.0K -187.0 (-0.8%) 48.7K +12.7K (+35.3%) 0.05% -0.002 pp 0.00% +0.000 pp USD2.59 -14.7% 3 qtrs —
63 PRICE T ROWE ASSOCIATES INC /MD/ 19.9K +— (+0.0%) 44.0K +11.0K (+33.3%) 0.05% -0.001 pp 0.00% +0.000 pp USD29.87 -92.6% 21 qtrs —
64 CREATIVE PLANNING 19.0K +3.2K (+20.1%) 42.1K +16.4K (+63.8%) 0.05% +0.007 pp 0.00% +0.000 pp USD6.55 -66.3% 13 qtrs —
65 CENTIVA CAPITAL, LP 18.5K +18.5K (+100.0%) 41.0K +41.0K (+100.0%) 0.05% +0.045 pp 0.00% +0.000 pp USD2.21 +0.0% 1 qtrs NEW
66 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 18.0K -373.0 (-2.0%) 39.7K +10.0K (+33.6%) 0.04% -0.002 pp 0.00% +0.000 pp USD6.39 -65.4% 7 qtrs —
67 LAZARD ASSET MANAGEMENT LLC 14.2K +14.2K (+100.0%) 31.3K +31.3K (+100.0%) 0.03% +0.035 pp 0.00% +0.000 pp USD2.21 +0.0% 6 qtrs —
68 REGATTA CAPITAL GROUP, LLC 13.7K +13.7K (+100.0%) 30.4K +30.4K (+100.0%) 0.03% +0.034 pp 0.00% +0.005 pp USD2.21 +0.0% 1 qtrs NEW
69 INTECH INVESTMENT MANAGEMENT LLC 12.8K -7.0K (-35.2%) 28.3K -3.7K (-11.6%) 0.03% -0.018 pp 0.00% +0.000 pp USD6.52 -66.1% 5 qtrs —
70 RUSSELL INVESTMENTS GROUP, LTD. 12.6K +5.6K (+79.4%) 27.8K +16.4K (+144.8%) 0.03% +0.013 pp 0.00% +0.000 pp USD1.88 +17.6% 2 qtrs —
71 CERITY PARTNERS LLC 12.4K +12.4K (+100.0%) 27.3K +27.3K (+100.0%) 0.03% +0.030 pp 0.00% +0.000 pp USD2.21 +0.0% 1 qtrs NEW
72 49 WEALTH MANAGEMENT, LLC 11.9K -2.6K (-17.8%) 26.3K +2.8K (+12.2%) 0.03% -0.007 pp 0.00% 0.000 pp USD1.62 +36.4% 2 qtrs —
73 HSBC HOLDINGS PLC 11.5K +— (+0.0%) 25.8K +7.0K (+37.0%) 0.03% -0.001 pp 0.00% +0.000 pp USD6.45 -65.7% 7 qtrs —
74 SG AMERICAS SECURITIES, LLC 10.7K -14.1K (-56.8%) 24.0K -16.0K (-40.0%) 0.03% -0.036 pp 0.00% 0.000 pp USD4.79 -53.9% 6 qtrs —
75 ABEL HALL, LLC 10.7K +10.7K (+100.0%) 23.5K +23.5K (+100.0%) 0.03% +0.026 pp 0.01% +0.006 pp USD2.21 +0.0% 1 qtrs NEW
76 INVESCO LTD. 10.6K +42.0 (+0.4%) 23.4K +6.3K (+37.0%) 0.03% 0.000 pp 0.00% +0.000 pp USD11.76 -81.2% 21 qtrs —
77 NINE MASTS CAPITAL LTD 10.1K +10.1K (+100.0%) 22.3K +22.3K (+100.0%) 0.02% +0.025 pp 0.00% +0.004 pp USD2.21 +0.0% 1 qtrs NEW
78 — 13.0K +13.0K (+100.0%) 20.0K +20.0K (+100.0%) 0.03% +0.032 pp 0.01% +0.005 pp USD2.21 +0.0% 1 qtrs NEW
79 BNP PARIBAS ARBITRAGE, SNC 8.9K +794.0 (+9.8%) 19.6K +6.5K (+49.8%) 0.02% +0.002 pp 0.00% +0.000 pp USD3.92 -43.6% 5 qtrs —
80 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 7.8K +— (+0.0%) 17.3K +4.6K (+36.4%) 0.02% 0.000 pp 0.00% +0.000 pp USD6.79 -67.5% 5 qtrs —
81 NEW YORK STATE COMMON RETIREMENT FUND 6.9K +— (+0.0%) 15.3K +4.1K (+36.4%) 0.02% 0.000 pp 0.00% +0.000 pp USD37.63 -94.1% 21 qtrs —
82 TOWER RESEARCH CAPITAL LLC (TRC) 4.7K -10.6K (-69.4%) 10.4K -14.5K (-58.3%) 0.01% -0.027 pp 0.00% 0.000 pp USD3.17 -30.3% 21 qtrs —
83 OPTIVER HOLDING B.V. 3.6K +3.0K (+482.3%) 8.0K +7.0K (+694.1%) 0.01% +0.007 pp 0.00% +0.000 pp USD2.11 +4.7% 2 qtrs —
84 CWM, LLC 3.8K +2.4K (+159.3%) 8.0K +6.0K (+300.0%) 0.01% +0.006 pp 0.00% +0.000 pp USD3.52 -37.2% 12 qtrs —
85 AMERITAS INVESTMENT PARTNERS, INC. 3.6K +— (+0.0%) 8.0K +2.1K (+36.4%) 0.01% 0.000 pp 0.00% +0.000 pp USD36.32 -93.9% 21 qtrs —
86 LEGAL & GENERAL GROUP PLC 3.6K -397.0 (-9.9%) 8.0K +1.5K (+22.9%) 0.01% -0.001 pp 0.00% +0.000 pp USD18.56 -88.1% 21 qtrs —
87 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2.4K +7.0 (+0.3%) 5.3K +1.4K (+36.8%) 0.01% 0.000 pp 0.00% +0.000 pp USD1.62 +36.4% 21 qtrs —
88 GAMMA INVESTING LLC 2.1K +2.1K (+100.0%) 4.7K +4.7K (+100.0%) 0.01% +0.005 pp 0.00% +0.000 pp USD2.21 +0.0% 1 qtrs NEW
89 ADVISOR GROUP HOLDINGS, INC. 1.4K +— (+0.0%) 3.2K +725.0 (+29.4%) 0.00% 0.000 pp 0.00% +0.000 pp USD15.23 -85.5% 17 qtrs —
90 ROYAL BANK OF CANADA 1.1K +656.0 (+160.8%) 3.0K +2.0K (+200.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD2.88 -23.3% 21 qtrs —
91 AMALGAMATED BANK 1.2K -113.0 (-8.5%) 3.0K +1.0K (+50.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD19.77 -88.8% 16 qtrs —
92 ADVISORNET FINANCIAL, INC 1.0K +— (+0.0%) 2.2K +590.0 (+36.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.62 +36.4% 2 qtrs —
93 CITIGROUP INC 875.00 -2.4K (-73.6%) 1.9K -3.4K (-64.0%) 0.00% -0.006 pp 0.00% +0.000 pp USD8.85 -75.0% 21 qtrs —
94 EVERSOURCE WEALTH ADVISORS, LLC 832.00 +783.0 (+1,598.0%) 1.8K +1.8K (+2,227.8%) 0.00% +0.002 pp 0.00% +0.000 pp USD2.25 -1.8% 5 qtrs —
95 PINNACLE WEALTH PLANNING SERVICES, INC. 695.00 +695.0 (+100.0%) 1.5K +1.5K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD2.21 +0.0% 1 qtrs NEW
96 FORTITUDE FAMILY OFFICE, LLC 592.00 +592.0 (+100.0%) 1.3K +1.3K (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD2.21 +0.0% 3 qtrs —
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 16 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Xtrackers S&P Global Infrastructure Swap UCITS ETF 1C XGID.L 0.07% 515.4K 0.60%
2 iShares Micro-Cap ETF IWC 0.01% 211.2K 0.60%
3 Vanguard Russell 2000 Growth ETF VTWG 0.00% 59.6K 0.06%
4 Vanguard Russell 2000 ETF VTWO 0.00% 305.1K 0.06%
5 Vanguard Extended Market ETF VXF 0.00% 704.1K 0.05%
6 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 11.1K 0.17%
7 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 4.0K 0.03%
8 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 817.16 0.17%
9 Vanguard Total Stock Market ETF VTI 0.00% 1.89M 0.03%
10 Vanguard Russell 3000 ETF VTHR 0.00% 4.1K 0.06%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.20
Bearish
Ratio by volume
3.00
Bullish
Buys
3
Sells
15
Shares acquired
425.0K
Shares disposed
98.3K
Cash buys
—
Cash sales
15.00
Net activity
+326,735
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-02 Rose Geoffrey Beran Officer S-Sale D Common Stock 835 1.43 1.2K 372,631 D ↗
2026-03-02 Radhakrishnan Srikanth Officer A-Award A Common Stock 175,000 0.00 — 345,736 D ↗
2026-03-02 Lehman David Aaron Officer S-Sale D Common Stock 4,051 1.43 5.8K 240,755 D ↗
2026-03-02 French Glendon E. III Director / Officer S-Sale D Common Stock 6,737 1.43 9.6K 1,467,879 D ↗
2025-12-08 Florin Daniel P Director S-Sale D Common Stock 23,321 1.99 46.4K 93,910 D ↗
2025-12-03 Radhakrishnan Srikanth Officer — — Employee Stock Option (right to buy) 1,383 1.40 1.9K 0 D ↗
2025-12-01 Sung Derrick Officer A-Award A Performance Stock Units 400,000 0.00 — 400,000 D ↗
2025-12-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 2,379 1.57 3.7K 373,466 D ↗
2025-12-01 Lehman David Aaron Officer S-Sale D Common Stock 3,401 1.57 5.3K 252,992 D ↗
2025-12-01 French Glendon E. III Director / Officer S-Sale D Common Stock 6,281 1.57 9.9K 277,324 D ↗
2025-11-03 Sung Derrick Officer — — Common Stock 0 0.00 — 135,319 D ↗
2025-09-02 Williamson Steven S. Director / Officer S-Sale D Common Stock 4,530 1.60 7.2K 358,967 D ↗
2025-09-02 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,575 1.60 2.5K 382,250 D ↗
2025-09-02 Lehman David Aaron Officer S-Sale D Common Stock 929 1.60 1.5K 272,110 D ↗
2025-09-02 Joshi Mehul Officer S-Sale D Common Stock 3,665 1.60 5.9K 208,489 D ↗
2025-06-12 Ferrari Richard Director S-Sale D Common Stock 8,000 3.16 25.3K 87,024 D ↗
2025-06-05 Florin Daniel P Director P-Purchase A Common Stock 23,321 3.06 71.4K 117,231 D ↗
2025-06-02 Williamson Steven S. Director / Officer S-Sale D Common Stock 4,661 3.13 14.6K 366,115 D ↗
2025-06-02 Sullivan Tiffany Director A-Award A Common Stock 37,153 0.00 — 75,199 D ↗
2025-06-02 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,576 3.13 4.9K 388,794 D ↗
2025-06-02 Melenikiotou Georgia Director A-Award A Common Stock 37,153 0.00 — 99,714 D ↗
2025-06-02 Mead Dana G Jr. Director A-Award A Common Stock 37,153 0.00 — 99,714 D ↗
2025-06-02 Lehman David Aaron Officer S-Sale D Common Stock 3,597 3.13 11.3K 278,421 D ↗
2025-06-02 Joshi Mehul Officer S-Sale D Common Stock 4,340 3.13 13.6K 217,646 D ↗
2025-06-02 French Glendon E. III Director A-Award A Common Stock 37,153 0.00 — 1,029,127 D ↗
2025-06-02 Florin Daniel P Director A-Award A Common Stock 37,153 0.00 — 93,910 D ↗
2025-06-02 Ferrari Richard Director A-Award A Common Stock 37,153 0.00 — 95,024 D ↗
2025-06-02 Burns Thomas William Director A-Award A Common Stock 37,153 0.00 — 73,399 D ↗
2025-03-20 French Glendon E. III Director S-Sale D Common Stock 20,000 7.85 157.0K 991,974 D ↗
2025-03-03 Williamson Steven S. Director / Officer S-Sale D Common Stock 27,689 7.14 197.7K 194,342 D ↗
2025-03-03 Rose Geoffrey Beran Officer S-Sale D Common Stock 2,327 7.14 16.6K 287,295 D ↗
2025-03-03 Lehman David Aaron Officer S-Sale D Common Stock 4,490 7.14 32.1K 191,515 D ↗
2025-03-03 Joshi Mehul Officer S-Sale D Common Stock 14,384 7.12 102.4K 113,986 D ↗
2025-02-20 French Glendon E. III Director S-Sale D Common Stock 43,036 8.14 350.3K 1,024,391 D ↗
2025-01-17 French Glendon E. III Director S-Sale D Common Stock 2,221 6.50 14.4K 1,067,427 D ↗
2025-01-16 French Glendon E. III Director S-Sale D Common Stock 2,326 6.53 15.2K 1,069,648 D ↗
2024-12-02 Rose Geoffrey Beran Officer S-Sale D Common Stock 690 6.18 4.3K 294,351 D ↗
2024-12-02 Lehman David Aaron Officer S-Sale D Common Stock 410 6.18 2.5K 202,938 D ↗
2024-11-22 French Glendon E. III Director S-Sale D Common Stock 20,000 6.63 132.6K 1,071,974 D ↗
2024-10-17 French Glendon E. III Director S-Sale D Common Stock 20,000 6.52 130.4K 1,091,974 D ↗
2024-09-12 French Glendon E. III Director S-Sale D Common Stock 20,000 8.09 161.8K 1,111,974 — ↗
2024-09-03 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,842 6.69 12.3K 297,043 — ↗
2024-09-03 Lehman David Aaron Officer S-Sale D Common Stock 429 6.71 2.9K 208,684 — ↗
2024-08-20 Williamson Steven S. Director / Officer P-Purchase A Common Stock 14,245 6.84 97.4K 219,531 — ↗
2024-06-24 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 6.16 7.3K 300,019 — ↗
2024-06-03 Sullivan Tiffany Director A-Award A Common Stock 15,216 0.00 — 38,046 — ↗
2024-06-03 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,510 6.97 10.5K 301,203 — ↗
2024-06-03 Melenikiotou Georgia Director A-Award A Common Stock 15,216 0.00 — 62,561 — ↗
2024-06-03 Mead Dana G Jr. Director A-Award A Common Stock 15,216 0.00 — 62,561 — ↗
2024-06-03 Lehman David Aaron Officer S-Sale D Common Stock 1,603 6.97 11.2K 209,113 — ↗
2024-06-03 French Glendon E. III Director A-Award A Common Stock 15,216 0.00 — 1,131,974 — ↗
2024-06-03 Florin Daniel P Director A-Award A Common Stock 15,216 0.00 — 40,968 — ↗
2024-06-03 Ferrari Richard Director A-Award A Common Stock 15,216 0.00 — 57,871 — ↗
2024-06-03 Burns Thomas William Director A-Award A Common Stock 15,216 0.00 — 36,246 — ↗
2024-05-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 8.71 10.3K 305,500 — ↗
2024-05-06 Joshi Mehul Officer A-Award A Employee Stock Option (right to buy) 241,409 9.28 2.24M 241,409 — ↗
2024-04-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 7.49 8.9K 306,684 — ↗
2024-04-03 Joshi Mehul — — — — 0 0.00 — 0 — ↗
2024-03-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 9.36 11.1K 307,868 — ↗
2024-03-15 Williamson Steven S. Director / Officer A-Award A Common Stock 205,286 0.00 — 205,286 — ↗
2024-03-01 Rose Geoffrey Beran Officer A-Award A Employee Stock Option (right to buy) 69,100 9.30 642.6K 69,100 — ↗
2024-03-01 McKune John Officer A-Award A Common Stock 14,400 0.00 — 61,810 — ↗
2024-03-01 Lehman David Aaron Officer A-Award A Employee Stock Option (right to buy) 69,100 9.30 642.6K 69,100 — ↗
2024-03-01 French Glendon E. III Director / Officer S-Sale D Common Stock 3,947 9.06 35.8K 1,116,758 — ↗
2024-02-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 14.20 16.8K 243,049 — ↗
2024-02-15 French Glendon E. III Director / Officer S-Sale D Common Stock 20,000 14.60 292.0K 1,121,344 — ↗
2024-01-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 13.13 15.5K 244,233 — ↗
2024-01-18 French Glendon E. III Director / Officer S-Sale D Common Stock 10,000 12.77 127.7K 1,141,344 — ↗
2023-12-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 12.75 15.1K 245,417 — ↗
2023-12-21 French Glendon E. III Director / Officer S-Sale D Common Stock 10,000 12.42 124.2K 1,151,344 — ↗
2023-12-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 396 10.34 4.1K 249,073 — ↗
2023-12-01 McKune John Officer A-Award A Common Stock 7,233 0.00 — 47,647 — ↗
2023-12-01 Lehman David Aaron Officer S-Sale D Common Stock 402 10.33 4.2K 153,246 — ↗
2023-12-01 French Glendon E. III Director / Officer S-Sale D Common Stock 1,040 10.34 10.8K 1,166,980 — ↗
2023-11-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 10.60 12.6K 249,469 — ↗
2023-10-23 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 8.35 9.9K 250,653 — ↗
2023-10-10 McKune John Officer — D Common Stock 0 0.00 — 41,356 — ↗
2023-09-22 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 10.51 12.4K 251,837 — ↗
2023-09-01 Sung Derrick Officer S-Sale D Common Stock 3,120 10.00 31.2K 391,041 — ↗
2023-09-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,759 10.01 17.6K 253,021 — ↗
2023-09-01 Lehman David Aaron Officer S-Sale D Common Stock 701 10.01 7.0K 156,321 — ↗
2023-09-01 French Glendon E. III Director / Officer S-Sale D Common Stock 3,921 10.01 39.2K 1,168,020 — ↗
2023-08-23 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,184 10.54 12.5K 255,864 — ↗
2023-07-20 French Glendon E. III Director / Officer S-Sale D Common Stock 15,000 12.68 190.2K 1,174,547 — ↗
2023-06-15 French Glendon E. III Director / Officer S-Sale D Common Stock 10,000 12.68 126.8K 1,189,547 — ↗
2023-06-01 Sung Derrick Officer S-Sale D Common Stock 3,122 11.49 35.9K 395,260 — ↗
2023-06-01 Sullivan Tiffany Director A-Award A Common Stock 12,620 0.00 — 22,830 — ↗
2023-06-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 1,760 11.48 20.2K 257,048 — ↗
2023-06-01 Melenikiotou Georgia Director A-Award A Common Stock 12,620 0.00 — 47,345 — ↗
2023-06-01 Mead Dana G Jr. Director A-Award A Common Stock 12,620 0.00 — 47,345 — ↗
2023-06-01 Lynch Alissa Hsu Director A-Award A Common Stock 12,620 0.00 — 24,530 — ↗
2023-06-01 Lehman David Aaron Officer S-Sale D Common Stock 2,676 11.48 30.7K 157,420 — ↗
2023-06-01 French Glendon E. III Director / Officer S-Sale D Common Stock 3,924 11.48 45.0K 1,199,547 — ↗
2023-06-01 Florin Daniel P Director A-Award A Common Stock 12,620 0.00 — 25,752 — ↗
2023-06-01 Ferrari Richard Director A-Award A Common Stock 12,620 0.00 — 42,655 — ↗
2023-06-01 Burns Thomas William Director A-Award A Common Stock 12,620 0.00 — 21,030 — ↗
2023-03-01 Sung Derrick Officer A-Award A Employee Stock Option (right to buy) 94,500 11.48 1.08M 94,500 — ↗
2023-03-01 Rose Geoffrey Beran Officer A-Award A Common Stock 78,900 0.00 — 259,893 — ↗
2023-03-01 Lehman David Aaron Officer A-Award A Common Stock 118,300 0.00 — 161,196 — ↗
2023-03-01 French Glendon E. III Director / Officer A-Award A Employee Stock Option (right to buy) 356,300 11.48 4.09M 356,300 — ↗
2022-12-01 Sung Derrick Officer S-Sale D Common Stock 387 5.93 2.3K 263,428 — ↗
2022-12-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 382 5.93 2.3K 181,710 — ↗
2022-12-01 Lehman David Aaron Officer S-Sale D Common Stock 387 5.93 2.3K 44,842 — ↗
2022-12-01 French Glendon E. III Officer S-Sale D Common Stock 2,195 5.93 13.0K 1,034,313 — ↗
2022-11-29 Lynch Alissa Hsu Director P-Purchase A Common Stock 1,700 5.51 9.4K 11,910 — ↗
2022-11-14 Sung Derrick Officer M-Exempt A Common Stock 10,000 2.20 22.0K 263,815 — ↗
2022-11-14 French Glendon E. III Officer M-Exempt A Common Stock 10,000 2.20 22.0K 1,037,944 — ↗
2022-11-08 Ferrari Richard Director P-Purchase A Common Stock 5,338 5.31 28.3K 29,935 — ↗
2022-09-01 Sung Derrick Officer S-Sale D Common Stock 392 17.87 7.0K 254,505 — ↗
2022-09-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 372 17.87 6.6K 182,747 — ↗
2022-09-01 Lehman David Aaron Officer S-Sale D Common Stock 392 17.89 7.0K 45,919 — ↗
2022-09-01 French Glendon E. III Officer S-Sale D Common Stock 1,014 17.87 18.1K 1,054,870 — ↗
2022-08-18 French Glendon E. III Officer S-Sale D Common Stock 50,000 20.59 1.03M 1,055,884 — ↗
2022-06-01 Sung Derrick Officer S-Sale D Common Stock 386 18.05 7.0K 255,576 — ↗
2022-06-01 Sullivan Tiffany Director A-Award A Common Stock 5,600 0.00 — 10,210 — ↗
2022-06-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 366 18.05 6.6K 183,763 — ↗
2022-06-01 Melenikiotou Georgia Director A-Award A Common Stock 5,600 0.00 — 34,725 — ↗
2022-06-01 Mead Dana G Jr. Director A-Award A Common Stock 5,600 0.00 — 34,725 — ↗
2022-06-01 Lynch Alissa Hsu Director A-Award A Common Stock 5,600 0.00 — 10,210 — ↗
2022-06-01 Lehman David Aaron Officer S-Sale D Common Stock 679 18.05 12.3K 46,311 — ↗
2022-06-01 French Glendon E. III Officer S-Sale D Common Stock 1,525 18.05 27.5K 1,104,994 — ↗
2022-06-01 Florin Daniel P Director A-Award A Common Stock 5,600 0.00 — 13,132 — ↗
2022-06-01 Ferrari Richard Director A-Award A Common Stock 5,600 0.00 — 24,597 — ↗
2022-06-01 Burns Thomas William Director A-Award A Common Stock 5,600 0.00 — 8,410 — ↗
2022-05-16 French Glendon E. III Officer G-Gift D Common Stock 25,000 0.00 — 1,107,517 — ↗
2022-03-10 Rose Geoffrey Beran Officer M-Exempt D Employee Stock Option (right to buy) 29,427 0.00 — 18,192 — ↗
2022-03-01 Sung Derrick Officer A-Award A Employee Stock Option (right to buy) 68,700 26.56 1.82M 68,700 — ↗
2022-03-01 Rose Geoffrey Beran Officer A-Award A Employee Stock Option (right to buy) 68,700 26.56 1.82M 68,700 — ↗
2022-03-01 Lehman David Aaron Officer S-Sale D Common Stock 458 25.91 11.9K 16,376 — ↗
2022-03-01 French Glendon E. III Director / Officer A-Award A Employee Stock Option (right to buy) 154,600 26.56 4.11M 154,600 — ↗
2022-02-18 French Glendon E. III Director / Officer S-Sale D Common Stock 8,561 26.81 229.5K 1,067,888 — ↗
2022-02-17 French Glendon E. III Director / Officer S-Sale D Common Stock 12,500 27.22 340.3K 1,076,449 — ↗
2022-01-21 French Glendon E. III Director / Officer S-Sale D Common Stock 200 24.73 4.9K 1,088,949 — ↗
2022-01-20 French Glendon E. III Director / Officer S-Sale D Common Stock 12,500 25.98 324.8K 1,101,449 — ↗
2021-12-16 French Glendon E. III Director / Officer S-Sale D Common Stock 18,402 30.74 565.7K 1,120,547 — ↗
2021-12-15 Sung Derrick Officer S-Sale D Common Stock 2,976 30.52 90.8K 225,444 — ↗
2021-12-15 Rose Geoffrey Beran Officer S-Sale D Common Stock 21,640 30.53 660.7K 123,819 — ↗
2021-12-14 Sung Derrick Officer S-Sale D Common Stock 3,000 32.89 98.7K 228,420 — ↗
2021-12-01 Sung Derrick Officer S-Sale D Common Stock 383 32.73 12.5K 231,420 — ↗
2021-12-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 355 32.73 11.6K 145,459 — ↗
2021-12-01 Lehman David Aaron Officer S-Sale D Common Stock 383 32.73 12.5K 16,834 — ↗
2021-12-01 French Glendon E. III Director / Officer S-Sale D Common Stock 1,421 32.73 46.5K 1,138,949 — ↗
2021-11-18 French Glendon E. III Director / Officer S-Sale D Common Stock 100 37.08 3.7K 1,105,470 — ↗
2021-11-15 Rose Geoffrey Beran Officer S-Sale D Common Stock 7,000 39.94 279.6K 145,814 — ↗
2021-10-21 French Glendon E. III Director / Officer S-Sale D Common Stock 8,597 39.99 343.8K 1,130,370 — ↗
2021-10-15 Rose Geoffrey Beran Officer S-Sale D Common Stock 7,000 39.44 276.1K 152,814 — ↗
2021-09-21 Sung Derrick Officer S-Sale D Common Stock 3,000 37.50 112.5K 231,803 — ↗
2021-09-20 Sung Derrick Officer S-Sale D Common Stock 115 37.96 4.4K 234,803 — ↗
2021-09-20 French Glendon E. III Director / Officer S-Sale D Common Stock 1,700 38.01 64.6K 0 — ↗
2021-09-16 French Glendon E. III Director / Officer S-Sale D Common Stock 25,000 38.86 971.5K 1,155,370 — ↗
2021-09-15 Rose Geoffrey Beran Officer S-Sale D Common Stock 7,000 38.12 266.8K 159,814 — ↗
2021-09-01 Sung Derrick Officer S-Sale D Common Stock 383 40.09 15.4K 237,803 — ↗
2021-09-01 Sullivan Tiffany Director A-Award A Common Stock 4,610 0.00 — 4,610 — ↗
2021-09-01 Rose Geoffrey Beran Officer S-Sale D Common Stock 355 40.09 14.2K 166,814 — ↗
2021-09-01 Lynch Alissa Hsu Director A-Award A Common Stock 4,610 0.00 — 4,610 — ↗
2021-09-01 Lehman David Aaron Officer S-Sale D Common Stock 383 40.09 15.4K 17,217 — ↗
2021-09-01 French Glendon E. III Director / Officer S-Sale D Common Stock 1,421 40.09 57.0K 1,180,370 — ↗
2021-08-19 French Glendon E. III Director / Officer S-Sale D Common Stock 1,000 36.59 36.6K 23,571 — ↗
2021-08-16 Rose Geoffrey Beran Officer S-Sale D Common Stock 7,000 36.71 257.0K 166,885 — ↗
2021-07-29 Sullivan Tiffany Director — — — 0 0.00 — 0 — ↗
2021-07-29 Lynch Alissa Hsu Director — — — 0 0.00 — 0 — ↗
2021-07-15 Rose Geoffrey Beran Officer S-Sale D Common Stock 758 37.57 28.5K 180,127 — ↗
2021-07-15 French Glendon E. III Director / Officer S-Sale D Common Stock 11,163 38.86 433.8K 1,219,234 — ↗
2021-07-13 BOSTON SCIENTIFIC CORP 10% Owner S-Sale D Common Stock 2,500,000 37.45 93.63M 1,488,106 — ↗
2021-07-12 Florin Daniel P Director P-Purchase A Common Stock 2,500 40.00 100.0K 7,532 — ↗
2021-06-25 Florin Daniel P Director P-Purchase A Common Stock 2,222 44.12 98.0K 5,032 — ↗
2021-06-17 French Glendon E. III Director / Officer M-Exempt A Common Stock 4,375 2.20 9.6K 1,252,359 — ↗
2021-06-01 Sung Derrick Officer A-Award A Employee Stock Option (right to buy) 39,900 43.40 1.73M 39,900 — ↗
2021-06-01 Rose Geoffrey Beran Officer A-Award A Employee Stock Option (right to buy) 39,900 43.40 1.73M 39,900 — ↗
2021-06-01 Melenikiotou Georgia Director A-Award A Common Stock 2,810 0.00 — 2,810 — ↗
2021-06-01 Mead Dana G Jr. Director A-Award A Common Stock 2,810 0.00 — 29,125 — ↗
2021-06-01 Lehman David Aaron Officer A-Award A Employee Stock Option (right to buy) 39,900 43.40 1.73M 39,900 — ↗
2021-06-01 French Glendon E. III Director / Officer A-Award A Common Stock 45,600 0.00 — 1,247,984 — ↗
2021-06-01 Florin Daniel P Director A-Award A Common Stock 2,810 0.00 — 2,810 — ↗
2021-06-01 FERRARI RICHARD M Director A-Award A Common Stock 2,810 0.00 — 18,997 — ↗
2021-06-01 Burns Thomas William Director A-Award A Common Stock 2,810 0.00 — 2,810 — ↗
2021-05-24 Rose Geoffrey Beran Officer S-Sale D Common Stock 400 41.55 16.6K 163,285 — ↗
2021-05-20 French Glendon E. III Director / Officer M-Exempt A Common Stock 10,000 2.20 22.0K 1,259,884 — ↗
2021-05-18 Rose Geoffrey Beran Officer M-Exempt A Common Stock 49,428 1.40 69.2K 166,101 — ↗
2021-05-10 Rose Geoffrey Beran Officer S-Sale D Common Stock 1 42.51 42.51 116,673 — ↗
2021-04-19 Rose Geoffrey Beran Officer S-Sale D Common Stock 4,797 43.24 207.4K 121,470 — ↗
2021-04-15 French Glendon E. III Director / Officer M-Exempt D Stock Option (Right to Buy) 25,000 2.20 55.0K 184,999 — ↗
2021-04-06 Sung Derrick Officer S-Sale D Common Stock 600 48.33 29.0K 218,659 — ↗
2021-04-06 BOSTON SCIENTIFIC CORP 10% Owner S-Sale D Common Stock 650,000 43.60 28.34M 3,988,106 — ↗
2021-04-05 Sung Derrick Officer S-Sale D Common Stock 220 48.56 10.7K 223,659 — ↗
2021-04-05 Rose Geoffrey Beran Officer S-Sale D Common Stock 266 48.46 12.9K 109,064 — ↗
2021-03-30 BOSTON SCIENTIFIC CORP 10% Owner S-Sale D Common Stock 1,350,000 40.80 55.08M 4,638,106 — ↗
2020-12-10 Rose Geoffrey Beran Officer M-Exempt D Employee Stock Option (right to buy) 22,000 1.40 30.8K 49,428 — ↗
2020-10-05 Melenikiotou Georgia Director P-Purchase A Common Stock 26,315 19.00 500.0K 26,315 — ↗
2020-10-05 Mead Dana G Jr. Director C-Conversion D Series E-1 Preferred Stock 87,475 0.00 — 0 — ↗
2020-10-05 Lindstrand Staffan Director C-Conversion A Common Stock 78,550 0.00 — 1,116,724 — ↗
2020-10-05 Lehman David Aaron Officer — D Employee Stock Option (right to buy) 125,000 19.00 2.38M 0 — ↗
2020-10-05 Florin Daniel P Director P-Purchase A Common Stock 15,789 19.00 300.0K 15,789 — ↗
2020-10-05 FERRARI RICHARD M Director C-Conversion D Series C-1 Preferred Stock 327,560 0.00 — 0 — ↗
2020-10-05 BOSTON SCIENTIFIC CORP 10% Owner C-Conversion D Series F-1 Preferred Stock 3,787,878 0.00 — 0 — ↗
2020-09-30 Sung Derrick Officer — D Common Stock 0 0.00 — 228,659 — ↗
2020-09-30 Rose Geoffrey Beran Officer — D Common Stock 0 0.00 — 113,861 — ↗
2020-09-30 Melenikiotou Georgia Director — — — 0 0.00 — 0 — ↗
2020-09-30 Mead Dana G Jr. Director — I Series D-1 Preferred Stock 168,223 0.00 — 0 — ↗
2020-09-30 Lindstrand Staffan Director — I Series C-1 Preferred Stock 13,252 0.00 — 0 — ↗

Executive team

Top executives
EBIT / Employee
-184.4K
Shares Outstanding
42.24M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2025 Steven S. Williamson Former Chief Executive Officer 493.5K — 2.26M 752.4K — 691.2K 4.20M 71.77% ↗
2 2025 Glendon E. French Chief Executive Officer 116.2K 50.0K 3.22M — — 153.3K 3.54M 90.98% ↗
3 2025 Derrick Sung Chief Operating Officer and Chief Financial Officer 83.3K 200.0K 2.67M — — 58.00 2.95M 90.40% ↗
4 2025 Mehul Joshi Former Chief Financial Officer 381.2K — 1.19M — — 408.8K 1.98M 60.18% ↗
5 2025 David Lehman General Counsel 472.4K — 1.19M — 43.8K 452.00 1.71M 69.79% ↗
6 2024 Steven S. Williamson Former Chief Executive Officer 461.4K — 1.84M 2.54M 357.1K 34.5K 5.23M 83.70% ↗
7 2024 Steven S. Williamson Chief Executive Officer 461.4K — 1.84M 2.54M 357.1K 34.5K 5.23M 83.70% ↗
8 2024 Mehul Joshi Chief Financial Officer 334.3K 200.0K 1.00M 1.51M 184.7K 14.7K 3.24M 77.38% ↗
9 2024 Mehul Joshi Former Chief Financial Officer 334.3K 200.0K 1.00M 1.51M 184.7K 14.7K 3.24M 77.38% ↗
10 2024 David Lehman General Counsel 458.6K — 642.6K 213.8K 169.4K 696.00 1.49M 57.67% ↗
11 2024 Glendon E. French Chief Executive Officer 195.6K — — — — 135.2K 330.8K 0.00% ↗
12 2024 Glendon E. French Former Chief Executive Officer 195.6K — — — — 135.2K 330.8K 0.00% ↗
13 2024 Derrick Sung Chief Operating Officer and Chief Financial Officer — — — — — — — — ↗
14 2023 Glendon E. French Chief Executive Officer 580.0K — 1.99M 2.77M 453.3K 666.00 5.80M 82.16% ↗
15 2023 Glendon E. French Former Chief Executive Officer 580.0K — 1.99M 2.77M 453.3K 666.00 5.80M 82.16% ↗
16 2023 Derrick Sung, Ph.D Former Chief Financial Officer 357.5K — 1.58M 734.6K — 555.00 2.68M 86.62% ↗
17 2023 David Lehman General Counsel 443.0K — 1.36M 629.6K 207.7K 666.00 2.64M 75.32% ↗
18 2023 Geoffrey Beran Rose Chief Commercial Officer 430.0K — 905.8K 419.8K 201.6K 666.00 1.96M 67.70% ↗
19 2022 Glendon E. French Chief Executive Officer 569.0K 215.9K 1.85M 1.82M 106.7K 666.00 4.57M 80.45% ↗
20 2022 David Lehman General Counsel 426.0K 97.0K 823.4K 809.4K 47.9K 666.00 2.20M 74.07% ↗
21 2022 Geoffrey Beran Rose Chief Commercial Officer 417.0K 95.0K 823.4K 809.4K 46.9K 1.4K 2.19M 74.45% ↗
22 2021 Glendon E. French Chief Executive Officer 550.0K 56.1K 1.98M 1.93M 292.1K 1.4K 4.81M 81.31% ↗
23 2021 David Lehman General Counsel 412.0K 25.2K 763.8K 744.1K 131.3K 666.00 2.08M 72.60% ↗
24 2021 Geoffrey Beran Rose Chief Commercial Officer 380.0K 23.3K 763.8K 744.1K 121.1K 666.00 2.03M 74.18% ↗
25 2020 Glendon E. French Chief Executive Officer 442.8K — — 2.75M 183.4K 666.00 3.37M 81.42% ↗
26 2020 David Lehman General Counsel 97.0K 50.0K — 1.22M — 111.00 1.36M 89.22% ↗
27 2020 Geoffrey Beran Rose Chief Commercial Officer 314.7K — — 426.4K 76.1K 666.00 817.9K 52.13% ↗
28 2019 Glendon E. French Chief Executive Officer 412.0K — — 546.3K 163.5K 642.00 1.12M 48.67% ↗
29 2019 Geoffrey Beran Rose Chief Commercial Officer 272.6K — — 137.2K 62.9K 642.00 473.3K 28.98% ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-22 DEFA14A ↗
2026-04-22 DEF 14A ↗
2025-04-08 DEFA14A ↗
2025-04-08 DEF 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-19 SD ↗
2026-05-04 10-Q ↗
2026-04-29 8-K ↗
2026-04-22 DEFA14A ↗
2026-04-22 DEF 14A ↗
2026-04-22 ARS ↗
2026-03-27 SC 13G/A ↗
2026-03-10 S-8 ↗
2026-03-10 10-K ↗
2026-03-09 SC 13G ↗

Executive team

NameTitleCompensationGender
Geoffrey Beran Rose Chief Commercial Officer 632.3K male
David A. Lehman General Counsel & Secretary 516.6K male
Glendon E. French Chief Executive Officer, President & Director 319.5K male
Derrick Sung Chief Financial Officer & Chief Operating Officer 283.4K —
Marcee Maroney Vice President of Marketing — female
Narinder S. Shargill Senior Vice President of Global Medical & Clinical Affairs — —
Sri Radhakrishnan Chief Science & Technology Officer — male
Srikanth Radhakrishnan Chief Science & Technology Officer — male
John McKune VP of Finance & Corporate Controller — male
Jérôme Erath Senior Vice President & GM of International — male
Lisa Paul Chief People Officer — female
ESG Rating
B-
MEDICAL - DEVICES
Rank: 119 out of 144
2026
E (Environmental)
50.0 / 62.5
Company / Sector avg.
S (Social)
63.3 / 68.9
Company / Sector avg.
G (Governance)
56.8 / 64.8
Company / Sector avg.
ESG Total
56.7 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices